Inactive Instrument
Sector dividends Proto Script Pharmaceutical Corp Other OTC
Stocks
US98474L1044
Business Support Services
|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 17-04-21 | Proto Script Pharmaceutical Enters Partnership with PAKmed | CI |
| 16-11-09 | Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 0.94% | 1.02% | 36.37x | 12.33x | 6.63x | 23.54x | 28.06x | 79.84B | |
| 0.98% | 1.06% | 38.09x | 5.06x | 1.27x | 13.64x | 14.23x | 16.93B | |
| 1.53% | 1.62% | 30.11x | - | 3.49x | 11.7x | 13.96x | 15.6B | |
| 3.63% | 3.89% | 20.27x | 7.11x | 2.07x | 10.2x | 12.48x | 14.18B | |
| 2.97% | 3.19% | 25.4x | 7.4x | 2.84x | 12.14x | 15.43x | 12.14B | |
| 2.3% | 2.56% | 25.19x | 6.08x | 3.51x | 13.51x | 18.05x | 8.05B | |
| 1.36% | 1.6% | 15.79x | 5.2x | 0.67x | 9.41x | 12.76x | 7.15B | |
| 2.2% | 2.46% | 9.54x | 2.08x | 1.13x | 6.02x | 6.4x | 5.69B | |
| 3.86% | 4.1% | 19.28x | 2.39x | 0.41x | 9.52x | 12.75x | 5.45B | |
| -.--% | -.--% | 20.49x | 6.01x | 2.21x | 10.42x | 15.05x | 5.28B | |
| 0.47% | 0.47% | 43.63x | 2.07x | 1.97x | 15.35x | 28.58x | 5.19B | |
| 0.93% | 0.88% | 16.23x | - | 1.19x | 6.28x | 8.51x | 4.71B | |
| 6.43% | 6.79% | 8.08x | 0.94x | 0.76x | 3.96x | 5.42x | 4.77B | |
| 1.85% | 2.07% | 15.92x | 3.2x | 0.65x | 6.68x | 11.07x | 3.54B | |
| 2.31% | 2.61% | 20.3x | 5.26x | 0.52x | 7.86x | 10.42x | 3.58B | |
| 3.03% | 3.23% | 13.72x | 1.43x | 0.84x | 6.73x | 9.48x | 3.57B | |
| 1.85% | 1.94% | 29.08x | 9.26x | 5.06x | 17.82x | 21.04x | 3.19B | |
| Average | 2.16% | 2.32% | 22.79x | 5.06x | 2.07x | 10.87x | 14.33x | 11.7B | |
| Weighted average by Cap. | 1.68% | 1.81% | 29.22x | 8.31x | 3.85x | 15.90x | 19.50x |
- Stock Market
- Stocks
- PSCR Stock
- Stock
- Sector Proto Script Pharmaceutical Corp
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
